QUANTITATIVE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPIC METHOD DEVELOPMENT AND VALIDATION OF SUMATRIPTAN SUCCINATE IN PHARMACEUTICAL TABLET DOSAGE FORM

Mangarao Nakka

Abstract


A new, simple and accurate quantitative proton nuclear magnetic resonance(qNMR) spectroscopic  method was developed to determine the sumatriptan succinate in pharmaceutical tablet formulation. In this developed quantitative nuclear magnetic resonance spectroscopy method,Maleic acid was used as internal standard(IS) due to there was no overlapping of the peak  to analyte peaks and deuterium oxide(D2O) was used as diluent. For the quantification of the sumatriptan succinate 4.43 ppm and 6.20 ppm  peaks were used as quantitative monitoring purpose to correspong to analyte sumatriptane succinate and Maleic acid internal standard(IS) respectively. The final optimized  method was validated as per International Conference on Hormonisation (ICH) guidelines in terms  of Specificity, Limit of detection (LOD), Limit of Quantitation (LOQ), Pecision, Linearity, Accuracy ,Solution stability and Robustness. This method could be used to determination of sumatriptane succinate  in bulk and  pharmaceutical  tablet dosage forms.


Keywords


Sumatriptan succinate, Quantitative nuclear magnetic resonance(qNMR) ,Internal standard, Method Validation

References


Hsu VD. Sumatriptan: a new drug for vascular headache. Clin Pharm. 1992; 11:919-29

Anon. Sumatriptan for migraine. Med Lett Drugs Ther. 1992; 34:91-3.

Ferrari MD and the Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991; 325:316-21.

Plosker GL, McTavish D. Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994; 47:622-51.

Bousser MG, d’Allens H, Richard A et al. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. J Int Med. 1993; 234:211-6.

Hoerlein M, McMonigle G, Franz DN. Sumatriptan therapy of pediatric migraines. Ann Neurol. 1994; 36:548.

F.Kasler,Quantitative analysis by NMR spectroscopy(Academic press,New York,1973)

Holzgrabe U, Diehl B and Wawer I, NMR Spectroscopy in Pharmaceutical Analysis, Elsevier Ltd., Oxford, UK, 2008, 49-50.

Rizzo, V, Pinciroli, V, Quantitative NMR in synthetic and combinatorialchemistry. J.Pharm.Biomed.Anal.38:2005,851-857

Malz,F.,Jancke,H. Validation of quantitative NMR,Journal of pharmaceutical and Biomedical analysis.38,2005,:813-823

Tanja,B.,Curd,S. The role of solvents in the signal separation for quantitative 1H-NMR spectroscopy,Journal of pharmaceutical and Biomedical analysis.2010,52:51-58

S. Ravi, Y. Darwis, N. Khan, Development and validation of an RP-HPLC–UV method for analysis of sumatriptan succinate in pharmaceutical dosage forms, Acta Chromatogr. 21 (2009) 421–432.

L. Singh, S. Nanda, R. Chomwal, A validated sensitive chromatographic method for the estimation of sumatriptan succinate in bulk drug and tablet dosage form, Chron. Young Sci. 2 (2011) 37–41.

Buridi.kalyana ramu* and K. Raghubabu. Estimation of sumatriptan succinate in bulk and formulations by visible spectrophotometry using aromatic aldehydes. Internation J of Applied Biology and Pharm tech 2011; Volume: 2: Issue-1: 86-91.

Rajesh Kumar N, Sunil Kumar S, Susanta Kumar P. Method development and validation of Sumatriptan in bulk and pharmaceutical dosage forms by UV spectrophotometric method. International journal of pharmaceutical and biological archives, 2011; 2: 1100-1105.

Kalyanaramu B, Raghubabu K. A simple visible spectrophotometric determination of Sumatriptan Succinate from pharmaceutical formulations. Der pharma chemical, 2011; 3: 223-228.

Amruta B.K, Upendra C.G, Shrikant W, Santhakumari B. Development and validation of a sensitive bio-analytical method for the determination of sumatriptan in rat plasma by UPLC-MS. International journal of pharmacy and pharmaceutical sciences, 2013; 5: 78-82.

Shah C R*, Suhagia B N, Shah N J, and Shah R R. Development and validation of a HPTLC method for the estimation of Sumatriptan in tablet dosage forms. Indian J of Pharm Sci 2008; Nov-Dec 70 (6): 831–834.

ICH Harmonized Tripartite Guidelines.Validation of analytical Procedures:Text and Methodolgy Q2(R1) 2005.




URN: https://pmindexing.com/index.php/IJCPA/issue/view/urn:pmi:jr:0011ijcpa.v5i2.14444

DOI: https://pmindexing.com/91.1211/ijcpa.v5i2.1444

Refbacks

  • There are currently no refbacks.